MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202647123031 A) filed by Immuneel Therapeutics Private Limited on October 14, 2026, for A Method For Preparing Chimeric Antigen Receptor (car) Expressing Cells.
Inventors include Kamat, Rohan Hemant; Chitirala, Praneeth; Karmakar, Souvik; and Gandikota, Lakshmikanth Satya.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: Present invention discloses a new method for manufacturing genetically engineered T cells expressing a chimeric antigen receptor (CAR) that provides several improvements over conventional manufacturing methods, thereby enabling production of a robust supply of clinically useful CAR T-cell therapies with higher percentage of CAR positive cells with improved naive and memory cells in a short timeframe and in a cost-effective manner. Further similar method can be used to manufacture NK-CAR, TIL and other immune effector cells useful for immunotherapy. This new method treats the patient/ human body as a bioreactor wherein the CAR-T cells expand on encountering the target antigen in their natural environment thus making them more efficient in terms of persistence and efficacy in neutralizing the tumours.
Disclaimer: Curated by HT Syndication.
